Murine bone marrow cells synthesize bone proteins, including alkaline phosphatase (ALP), collagen type 1, and osteocalcin, and form a mineralized extracellular matrix when cultured in the presence of @-glycerophosphate and vitamin C. Interleukin-I 0 (IL-1 0) suppressed the synthesis of these bone proteins and mineralization without affecting cell proliferation. In addition, mRNA levels for the latter proteins were reduced in IL-I 0-treated cultures. This inhibitory effect was most outspoken when IL-I 0 was added before ALP activity peaked, eg, day 1 5 of culture. No significant effect was observed when IL-I 0 was added at later time points. This finding suggests that IL-10 acts at osteogenic differentiation stages that precede ALP expression but is ineffective on cells that progressed beyond this maturation stage. Likewise, IL-10 appeared to be unable to block both ALP activity and collagen synthesis in the preosteosteoblastic cell lines MN7 and MC3T3 that constitutively synthesize these proteins. Whereas IL-I 0 did AINTENANCE of bone volume is the result of a
By Peter Van Vlasselaer, Brigitte Borremans, Rosette Van Den Heuvel, Urbain Van Gorp, and Rene de Waal Malefyt
Murine bone marrow cells synthesize bone proteins, including alkaline phosphatase (ALP), collagen type 1, and osteocalcin, and form a mineralized extracellular matrix when cultured in the presence of @-glycerophosphate and vitamin C. Interleukin-I 0 (IL-1 0) suppressed the synthesis of these bone proteins and mineralization without affecting cell proliferation. In addition, mRNA levels for the latter proteins were reduced in IL-I 0-treated cultures. This inhibitory effect was most outspoken when IL-I 0 was added before ALP activity peaked, eg, day 1 5 of culture. No significant effect was observed when IL-I 0 was added at later time points. This finding suggests that IL-10 acts at osteogenic differentiation stages that precede ALP expression but is ineffective on cells that progressed beyond this maturation stage. Likewise, IL-10 appeared to be unable to block both ALP activity and collagen synthesis in the preosteosteoblastic cell lines MN7 and MC3T3 that constitutively synthesize these proteins. Whereas IL-I 0 did AINTENANCE of bone volume is the result of a M balance between its continuous formation and destruction. This process requires complex sequences of cellular events that are modulated by site-and cell-specific signals capable of initializing and promoting the recruitment and proliferation of the appropriate cells at the right time. Cytokines represent a group of (glyco) proteins that mediate immune responses. In addition, cytokines have been shown to influence bone biology' and to play a role in certain bone pathologies, eg, o~teopetrosis?~ postmenopausal osteoporos~s,~,' and rheumatoid arthriti~.~. ' In mouse and human, two subsets of helper T cells have been defined based on their cytokine secretion patterns and their functional role in the immune response.' T-helper 1 (Th 1) cells produce interleukin-2 (IL-2) and interferon-y (IFN-y) and are involved in delayed type hypersensitivity (DTH) reactions, whereas T helper 2 (Th 2) cells provide help for antibody responses and produce IL-4, IL-5, and IL-6. Recently, a novel cytokine was cloned from Th 2 cells and was designated IL-10.9,10 This factor was first identified as cytokine synthesis-inhibiting factor (CSIF)," but subsequent studies showed its pleiotropic activities. Apart from its inhibitory activity on Th 1 cytokine ~ynthesisl~,'~ and macrophage f~nctions,'~,'~ IL-10 stimulated the growth of mast cells,I6 B cells," and thymocytes."
Mediators of both Th 1 and Th 2 responses, particularly IL-1, IL-3, IL-4, IL-6, tumor necrosis factor-a (TNF-a), granulocyte-macrophage colony-stimulating factor (GM-CSF), and IFN-y, were documented to influence bone biology. Their impact on the in vitro generation and maturation of osteoclasts and osteoblasts received a lot of attention and has in many cases been correlated with anabolic and/or catabolic activities on bone in V~V O .~, '~,~~ Most of this information was obtained from studies on mouse and rat calvaria cells in vitro and, consequently, is restricted to effects on mature osteoblastic cells. Little is known about the effect of cytokines on the progression of'boncommitted" mesenchymal cells through the consecutive steps of osteoblastic differentiation.
Bone marrow stroma forms a complex network of fibronot alter the number of fibroblast colony-forming cells of the marrow, it significantly reduced their osteogenic differentiation potential. In contrast to control cultures, IL-I 0-treated stroma was unable to either synthesize osteocalcin or to mineralize when subcultured over a 25-day period in the absence of IL-I 0. The inhibitory activity of IL-10 coincided with significant changes in stroma morphology. Whereas control cultures contained mainly flat adherent polygonal cells, significant numbers of rounded semiadherent to nonadherent cells were observed in the presence of IL-10. Scanning and transmission electron microscopy showed that, in contrast to control cultures, IL-1 0-treated stromas completely lacked a mineralized extracellular matrix. Collectively, these data suggest that IL-l 0 may have important regulatory effects on bone biology because of its capacity to downregulate early steps of osteogenic differentiation. 0 1993 by The American Society of Hematology.
blasts, adipocytes, endothelial cells, and macrophages that supports hematopoiesis. 21 In addition, it is believed to harbor undifferentiated mesenchymal cells that form mineralized bony structures in vitro and bone ossicles when transplanted under the kidney capsule or when cultured in intraperitoneally implanted diffusion chamber^^^-'^ (Falla et al, submitted for publication). In the search for new biologic activities of IL-10, its effect was investigated on the osteogenic potential of mouse bone marrow. The present study shows that IL-10 inhibits the potential of mouse bone marrow to synthesize bone-related and specific proteins, including alkaline phosphatase (ALP), collagen type I, and osteocalcin, and to mineralize by interfering with early steps of osteogenic differentiation. bris and remaining aggregates were removed by passing the cell suspension over a 100 mesh stainless steel. Red blood cells were removed by density centrifugation on 70% Percoll (Pharmacia, Uppsala, Sweden). Cell culture. Bone marrow cells were suspended in Iscove's medium supplemented with 10% fetal calf serum (FCS), L-Glu, penicillin, streptomycin, ascorbic acid ( 100 g/mL), and P-glycerophosphate (0.6% wt/wt) and plated in flat-bottom 96-well plates at 5 X IO4 cellsper well. Purified, recombinant mouse IL-IO (specific activity, 2 x IO' U/mg) was added at different concentrations and time points to the cultures as stated in the text. To score cell proliferation, ['HI-thymidine (1 pCi/well) was added to each well and the cultures were harvested and counted in a liquid scintillation counter.
ALP activity. ALP activity was measured as described elsewhere.25 The cultures were incubated with 0. I mol/L sodium acetate solution, supplemented with 0.1% Triton X 100 and 5 mmol/L p-nitrophenol phosphate (Sigma 104; Sigma, St Louis, MO), pH 9.6, for 1 hour at 37°C. Absorbance was determined at 405 nm and compared with a p-nitrophenol standard titration curve. ALP activity was expressed as nanomoles of p-nitrophenol formed per minute.
Collagen synthesis. Collagen synthesis was measured as the incorporation of ('H)-proline (Amersham, UK) into collagenase-digestible protein (CDP).26 Collagenase was purchased from Worthington (UK) and was substantially free of nonspecific protease activity. Cell cultures were exposed to ('H)-proline ( 1 pCi/well) for 18 hours at 37°C and then washed three times with phosphate-buffered saline (PBS). Collagenase (0.1 mg/mL in PBS) was added for 1 hour and the CDP was measured in a liquid scintillation counter.
Osteocalcin cell enzyme-linked immunosorbent assay (ELISA).
The osteocalcin cell ELISA was performed as described elsewhere (Falla et al. submitted for publication). Briefly, the cultures were rinsed with PBS, fixed with 4% cold formaldehyde for 30 minutes at 4°C and then washed twice with Tris/HCI 0.05 mol/L, pH 7.6. Endogenous peroxidase activity was blocked by 5 minutes of incubation at room temperature with 3% H202. The samples were rinsed with Tris/HCI, pH 7.6, and blocked with normal goat serum (1/5 diluted in Tris/HC1, pH 7.6) for 1 hour at 37°C. Rabbit antimouse osteocalcin (kindly provided by Dr R. Bouillon, K. U. Leuven, Leuven, Belgium) was added at a dilution of 1/5,000 and incubated for 2 hours at 4°C. Nonbound serum was removed and the cultures were washed five times with Tris/HCI buffer. Horseradish peroxidase-conjugated goat antirabbit Ig serum (1/2,000 diluted in Tris/HCI, pH 7.6; Tago) was added for 30 minutes at 4°C. After intensive rinsing, the cultures were incubated at 37°C in the presence of ABTS substrate solution (ABTS 1 mg/mL + H,02 0.1 pL/mL in citric acid/Na2HP04, 10.5 d14.2 g/500 mL HzO) was added until coloration occurred. Absorbance was read in a microtiter reader at 450 nm with a reference of 650 nm. To control nonspecific binding of the antimouse osteocalcin antiserum, nonimmune rabbit serum was used under the same conditions. The amount of osteocalcin incorporated in the culture was determined in comparison with a standard ELISA of purified mouse osteocalcin (kindly provided by Dr R. Bouillon). The sensitivity of this assay was 0.3 ng/mL, whereas no reactivity was observed with FCS.
Calcium determination. Calcium was determined as described elsewhere." The cultures were washed three times with Ca2+ and Mg2+ free PBS and incubated overnight at room temperature in 0.6 N HCI. The extract was transferred to a 96-well plate and calcium was complexed with o-cresol-phthalein-complexon (Test Combination Calcium; Boehringer Mannheim, Mannheim, Germany). The colorimetric reaction was read at 570 nm in a spectrophotometer. The absolute calcium concentration wasdetermined in comparison with a standard curve for calcium provided by the vendor.
Qiiantijication q[jihrohlast colonpforminR cells (CFU-F).
The number of CFU-F was scored as described elsewhere." Briefly, 5-FU-treated bone marrow cells were prepared as described above and plated in 35-mm culture dishes (Falcon) at 5 X IO4 cells per dish. Replicate cultures were incubated at 37OC for IO days and fed once by total replacement ofthe medium. Adherent cells were fixed with methanol and stained with May-Grllnwald-Giemsa. Colonies of adherent, fibroblastic cells were scored under a binocular (20 x).
RNA preparation and Northern blot. Total cellular RNA was prepared by acid guanidine thiocyanate/phenol/chloroform extraction as described elsewhere.29 The RNA was fractionated by electrophoresis in I .5% agarose containing 10 mmol/L sodium phosphate after denaturation with glyoxal and dimethylsulfoxide. RNA was transferred to Biodyne filters (Pall) and hybridized to 32P-labeled alkaline phosphatase, collagen type 1, and osteocalcin cDNA probes that were kindly provided by Dr B. Mintz,M Dr Mon-Li C~U ,~' and the Genetics In~titute,~' respectively. Hybridization and washings were performed according to the manufacturer'sguidelines. Autoradiographic exposure was performed onto Kodak Ortho G X-ray films (Eastman Kodak, Rochester, NY).
Scanning and transmission electron microscop.v. For scanning electron microscopy, the cultures were rinsed with PBS and fixed for I hour with sodium-cacodylate buffer in 0. I mol/L phosphate buffer (pH 7.2). After rinsing, the cultures were postfixed for 1 hour with I% osmium tetroxide in the same buffer. The cultures were subsequently rinsed and progressively dehydrated with alcohol. They were processed for critical point drying(Ba1zers Union, Liechtenstein) in C02 and coated with gold (50 nm: Balzers Union). The cultures were observed in a JEOL JSM-FI5 microscope. For transmission electron microscopy, the cultures were washed once with PBS and then fixed for 2 hours in a glutaraldehyde (3%). paraformaldehyde ( 1%). sucrose (5%) solution in sodium-cacodylate buffer (0. I mol/L, pH 7.2) at 4°C. The cultures were subsequently washed twice in the same buffer and then postfixed for I hour in osmium tetroxide in the same buffer. After deshydratation of the cultures with alcohol, the samples were embedded in Epon. Sections were prepared on an LKB ultramicrotome. stained with uranyl acetate and lead citrate, and analyzed on a JEOL I200 EX microscope.
RESULTS
IL-10 inhibits the osteogenic activity of murine bone marrow ~i t h o~t affecting cell proliferation. Bone marrow cells synthesized several bone proteins, including ALP, collagen type I, and osteocalcin, and formed a mineralized extracellular matrix when cultured in the presence of 8-glycerophosphate and vitamin C. To determine the effect of IL-10 on these phenomena, IL-IO was added at the onset of these cultures and bone protein synthesis and the degree of mineralization was determined at 3-day intervals. Figure 1 shows that ALP activity, collagen and osteocalcin synthesis, and calcium incorporation in the extracellular matrix is maximal around days 15, 18, 24. and 27 of culture, respectively.
Whereas IL-IO did not affect the ongoing synthesis of ALP and collagen during the first 9 days ofthe culture, it reduced the levels of both proteins by 40% at the moment of their maximal synthesis. The strongest suppressive effect of IL-IO was observed on osteocalcin synthesis and mineralization, which was reduced up to 80%. This inhibition occurred at the transcription level because Northern blot analysis illustrated that IL-IO reduced the bone protein mRNA level as well (Fig 2) . It is unlikely that IL-IO exerts its suppressive effect via specific cytotoxic activity on osteogenic cells because IL-IO-treated bone marrow cells synthesized ALP, collagen, and osteocalcin in quantities similar to untreated marrow when IL-IO was washed out of the cell suspension after 12 hours of incubation (data not shown). The inhibitory effect of IL-IO was reversed in the presence of the neutralizing anti-lL-I0 monoclonal antibody (MoAb) SXCl, showing the specificity of the reaction (Fig 3) . Interestingly, the SXCl MoAb did not alter ALP activity, collagen and osteocalcin synthesis, and mineralization in control cultures, suggesting that IL-IO is not endogenously produced. We next determined whether the suppressive effects of IL-IO were due to a direct inhibiting effect on cell proliferation. To this end, cultures were performed in the presence of IL-10 (2.5 X IO' U/mL) and proliferation was determined at 3-day intervals by measurement of ['HI-thymidine incorporation. Figure 4 shows that the level and kinetics of proliferative responses were not affected and even slightly elevated in cultures containing IL-10.
D&erential eflect of IL-IO on early and late stages of in vitro osteogenic differentiation. The temporal expression of bone-related proteins in these cultures reflects the progression of uncommitted cells through the consecutive steps of osteoblastic differentiation, eg, proliferation, matrix maturation, and mineralization. Consequently, this culture system allowed the determination of the susceptibility of each of these steps to IL-10 activity. Cultures were supplemented with IL-10 (2.5 X lo3 U/mL) at 5-day intervals and ALP activity, collagen and osteocalcin synthesis, and the degree of mineralization were determined after 30 days of cultivation. Figure 5 shows that bone protein synthesis and mineralization were significantly suppressed when IL-10 was added during the first I5 days ofcultivation, but that little or no effect was observed when it was added at later time points. Hence, it appears that the suppressive activity of IL-10 is restricted to osteogenic differentiation stages that precede ALP expression and that cells that were already synthesizing ALP are resistant to the suppressive effects of IL-10. Consistent with this idea was the finding that IL-10 (5 x lo3 U/mL) did not affect ALP activity and collagen synthesis by the preosteoblastic cell lines, MN733 and MC3T3,34 which synthesize ALP and collagen constitutively (Fig 6) . IL-IO does not affect the frequency of CFU-F, but changes their osteogenic differentiation potential. The above findings suggest that IL-10 exerts its suppressive activity on early, but not on late steps in osteoblastic differentiation. Because the fibroblastic compartment of the bone marrow is believed to harbor precursor cells of the osteogenic lineage,35 IL-10 activity could a priori result from a suppressive effect on the number of CFU-F. To analyze this possibility, CFU-F colony formation was measured in the presence of different concentrations of IL-10. Figure 7 shows that, although concentrations were used that completely blocked the formation of a mineralized matrix, IL-10 did not exert a notable effect on the number or size (data not shown) of the CFU-F colonies measured after 10 days of culture. This illustrates once more that IL-10 does not act via a specific cytotoxic effect on osteogenic cells. Indeed, because the latter cells represent 30% of the CFU-F (Falla et al, submitted for publication), the depletion of this population would be noticed in CFU-F analysis. In addition, the effect of IL-10 on the osteogenic potential ofthe CFU-F was determined by growing the cells in the absence or presence of IL-10 (2.5 X lo3 U/mL) until mineralization occurred in the control cultures, eg, day 15. At that time point the cells were subcultured for 30 additional days in the absence of IL-10. At 5-day intervals, ALP activity, collagen and osteocalcin synthesis, and the degree of mineralization were determined. Figure 8 shows that ALP activity and collagen synthesis were comparable in control and IL-10-treated cultures. In contrast, osteocalcin synthesis and mineralization increased in function of time in the control cultures, whereas these parameters did not exceed background levels in IL-1 O-pretreated cultures.
Morphologic changes in bone marrow cultures induced by IL-IO.
Coinciding with the suppressive activity on bone protein synthesis and mineralization, microscopic observation showed dramatic changes in the morphology of IL-10-treated bone marrow cultures (Fig 9) . Whereas control cultures were predominantly composed of adherent, flbt polygonal cells, large numbers of rounded, semiadherent, and nonadherent cells appeared in the cultures containing IL-10. The latter cells formed clusters in close contact with spaces. In contrast, no collagenous material or mineral deposits were observed in IL-10-treated cultures that contained mainly round and large flattened fibroblastic cells. In transmission electron microscopy, the fibroblastic cells in the control cultures displayed a large nucleus and a notable rough endoplasmatic reticulum. Electron dense matrix vesicles and mineralization sites were observed within the collagenous matrix. In contrast, IL-10-treated cultures contained mainly monocyte-like cells displaying phagocytized material in their vacuoles. No collagenous material or mineralized areas were observed in the extracellular spaces.
DISCUSSION
Cultured bone marrow from normal and 5-FU-treated animals synthesizes bone-related proteins, including ALP,36 collagen type I,37 and osteocalcin, a protein that is exclusively synthesized by cells ofthe bone lineage.38 Moreover, a mineralized matrix is formed in these cultures after prolonged culturing. The temporal expression of these different bone proteins and mineralization reflects the progression of osteogenic precursor cells through the stages of osteoblastic differentiation in vitro" (Falla et al, submitted for publication). In the present study, we showed that purified recombinant mouse IL-10 suppresses the sequential display of ALP activity, collagen and osteocalcin synthesis, and mineralization in vitro. IL-10 did not affect ongoing synthesis of ALP and collagen during the first 9 days of the culture, but maximally suppressed these proteins at days 15 and 18, respec- For For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From tively. These suppressive effects are not due to a shift in kinetics because identical expression patterns of bone-related proteins and mineralization were observed in the absence or presence of IL-10. The inhibitory effects are specific for IL-10 because they were completely neutralized in the presence of the IL-10-specific MoAb SXC 1. Interestingly, this MoAb did not affect bone protein synthesis and mineralization in control cultures, indicating that IL-10 was not endogenously produced. IL-10 activity on bone protein synthesis and mineralization does not appear to result from an overall suppressive effect on proliferation, as measured by thymidine incorporation. However, care should be take because it has been shown that IL-10 has differential effects on different cell type^'^-'^,^^^' and may therefore stimulate proliferation of a particular cell population while blocking DNA synthesis of osteoprogenitor cells. However, it is unlikely that IL-10 specifically suppressed the proliferation of osteoprogenitor cells because IL-10 did not affect the number or size (data not shown) of the CFU-F colonies that are believed to harbor the osteoprogenitor cell^.^' In addition, IL-10 did not affect DNA synthesis in the preosteoblast cell lines MN7 and MC3T3 (data not shown).
IL-10 affected cellular events that determine osteogenic differentiation and that precede the acquisition of ALP activity, collagen and osteocalcin synthesis, and the potential of marrow cells to form a mineralized extracellular matrix.
Indeed, suppressive effects on bone protein synthesis and mineralization were only observed when IL-10 was added to the cultures before maximal ALP synthesis occurred, eg, at day 15 of culture. IL-IO was ineffective when added after this time point. This finding suggests that IL-IO is able to block de novo but not ongoing synthesis of bone proteins. This notion was supported by the observation that IL-10 was ineffective in reducing ALP and collagen synthesis in the preosteoblastic cell lines MN7 and MC3T3, which constitutively synthesize these proteins. Although these data roughly indicate at which level IL-IO affects osteogenic differentiation, its mechanism of action remains unsolved. Furthermore, it remains to be determined whether its effect is direct or indirectly mediated by other factors. In this context, recent experiments showed that transforming growth factor-/3 (TGF-P) synthesis is significantly reduced in IL-10-treated bone marrow cultures (Van Vlasselaer et al, manuscript submitted). This is of particular interest because the role of TGF-P in osteoblastic differentiation and proliferation has been documented Osteogenic precursor cells are believed to be undifferentiated mesenchymal cells belonging to the fibroblastic compartment of the bone m a r r o~.~~,~ It is obvious that changes in the frequency or the outgrowth of CFU-F in vitro could a priori be a valid explanation for the suppressive activity of IL-10. However, this study showed that, despite the fact that IL-10 was used at concentrations that completely blocked the formation of mineralized nodules, it did not affect the number or size of CFU-F colonies. Consequently, we suggest that IL-10 directs CFU-F differentiation away from bone development. Furthermore, the observation that IL-1 O-treated cultures were unable to synthesize osteocalcin and to mineralize upon subcultivation in the absence of IL-10 supports the notion that these effects of IL-10 on bone marrow stroma differentiation are irreversible under the culture conditions used.
The results shown in this report could hypothetically be explained by a selective toxicity of IL-10 to cells capable of producing ALP, collagen, and osteocalcin. It is at least clear that IL-10 is not cytotoxic for cells committed to the osteogenic lineage because IL-1 O-induced suppression occurred only when IL-10 was added to the culture before ALP activity started to increase. Furthermore, it is unlikely that IL-IO exerts cytotoxic effects on earlier osteogenic differentiation stages because ( I ) IL-lO-treated bone marrow showed osteogenic activity equal to control cells when IL-10 was washed out of the cell suspension after 12 hours of incubation; (2) IL-10 does not reduce CFU-F frequencies, although this could be expected based on the fact that osteogenic cells represent approximately 30% of the CFU-F population; and (3) recent data showed that the suppressive effect of IL-10 could be reversed by adding exogenous TGF-01 to the culture (Van Vlasselaer et al, submitted for publication).
Compared with control cultures, which are composed of predominantly flat polygonal cells, stromal morphology was drastically changed in the presence of IL-10. In the latter cultures semiadherent and nonadherent cells occurred as "cobblestone-like" structures in close contact with underlying stroma of reticular and fibroblastic cells displaying extended cytoplasmic protrusions. In many respects, the IL-1 O-containing cultures resembled hematopoietic cultures of the Dexter type.45 This is again compatible with the induction of hematopoiesis observed in cultures supplemented with IL-10 and further supports our hypothesis that IL-10 directs stromal differentiation towards hematopoietic support. Scanning electron microscopy showed the presence of a mineralized matrix that fills the extracellular spaces in control but not in IL-1 O-treated cultures. Moreover, the latter cultures contained large flat cells that formed a "blanket cell" stroma characteristic for cultures in which active hematopoiesis occurs.45 In transmission electron microscopy, control cultures were mainly composed of fibroblastic cells with a well-developed rough endoplasmatic reticulum and a large nucleus. Collagenous material with electron dense matrix vesicles could be observed between these cells. In contrast, the IL-1 O-treated cultures contained predominantly monocytic cells displaying membrane ruffling and phagocytized material within their vacuoles.
Collectively, our data show the suppressive activity of IL-10 on the in vitro osteogenic activity of mouse bone marrow. This novel biologic activity does not result from a direct effect of IL-10 on the expression of bone related proteins but results from IL-10 inhibitory effect on the commitment of mesenchymal cells towards the bone lineage. These findings may be of particular importance in certain in vivo conditions in which IL-10 synthesis is increased. In this context, the role of IL-IO in bone pathologies associated with (1) Th 2-mediated infectious disorders, eg, lepromatous Mycobacterium l e~r a e~~; or (2) excess numbers of mast cells, eg, systemic mastocytosis4'; awaits further investigation. For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From
